Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Key concepts in glioblastoma therapy

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Idiopathic intracranial hypertension: consensus guidelines on management

    Research output: Contribution to journalReviewResearchpeer-review

  1. Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical and histopathological predictors of outcome in malignant meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Adaptive hybrid surgery analysis (AHSA) for adjuvant gamma knife radiosurgery treatment of vestibular schwannoma residuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Response to: neurosurgical procedures performed during residency in Europe-preliminary numbers and time trends

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Glioblastoma is the most common form of primary brain cancer and remains one of the most aggressive forms of human cancer. Current standard of care involves maximal surgical resection followed by concurrent therapy with radiation and the DNA alkylating agent temozolomide. Despite this aggressive regimen, the median survival remains approximately 14 months. Meaningful strategies for therapeutic intervention are desperately needed. Development of such strategies will require an understanding of the therapeutic concepts that have evolved over the past three decades. This article reviews the key principles that drive the formulation of therapeutic strategies in glioblastoma. Specifically, the concepts of tumour heterogeneity, oncogene addiction, non-oncogene addiction, tumour initiating cells, tumour microenvironment, non-coding sequences and DNA damage response will be reviewed.

Original languageEnglish
JournalJournal of neurology, neurosurgery, and psychiatry
Volume83
Issue number7
Pages (from-to)753-60
Number of pages8
ISSN0022-3050
DOIs
Publication statusPublished - Jul 2012

    Research areas

  • Brain Neoplasms, Combined Modality Therapy, DNA Damage, DNA, Neoplasm, Glioblastoma, Humans, Oncogenes, RNA, Untranslated, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review

ID: 49729579